Genetic and transcriptome analyses revealed that EphB2 is amplified [34] or upregulated by EPN-ZFTA in supratentorial ependymoma [36], and EphB2 is a signature tyrosine kinase of the BL2 subtype in TNBC [29,32]. This evidence concerns the gene EPHB2 and ependymoma.